Our goal is to help doctors and scientists detect disease faster and with more specificity than ever before.

Genopsys has developed a way to modify proteins, giving them Velcro®-like sections that stick to certain, specific molecules. By tailoring the sticky sections so they recognize only select target molecules, and by inserting them into key places within a protein chain, we aim to make proteins capable of binding exclusively to their select targets. Our technology will one day allow scientists to manufacture proteins capable of "sticking" to specific cancer cells and disease-related molecules. In the future this high degree of specificity may allow medical professionals to detect diseases before they have progressed and become more difficult to cure.

How do our modified proteins detect disease? The proteins we work with act like light switches. In addition to targeting specific molecules and binding to them, our modified proteins can also cause certain other molecules to change color. Once the proteins have bound to a highly-specific disease related cell or molecule, the "molecular light-bulbs" are added, and we observe the color they emit when our proteins come into contact with them.

This technology facilitates the identification of cells and their components in an entirely unique way. When perfected, this technology will facilitate the development of new screening and detection tests.

But this is just one of the many potential applications of our research. These proteins can be engineered to bind to any number of unique molecules, so that industries besides healthcare may benefit as well.

Genopsys idsPCR™ / SCRAM™ - Directed Evolution Technology
idsPCR™ / SCRAM™ is Genopsys’ own patented approach to protein engineering. idsPCR™ / SCRAM™ is a directed evolution method that allows for the tunable introduction of amino acid diversity at any position in a protein. idsPCR™ / SCRAM™ allows proteins to be modified rapidly and with a high degree of specificity. This technology will allow us to perfect and fine-tune the properties of our proteins that are so critical to the detection process. In combination with high-throughput screening capabilities, this process yields proteins with significantly improved performance characteristics and broad patent protection.